|
|
|
|
|
|
|
||||
|
||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ThePharmYard provides instant access to a unique database of specialist information which is particularly relevant to individuals working within the medical and pharmaceutical industries around the world. Titles from a diverse range of independent publishers are available to purchase in electronic document format for immediate access.
Number of publications currently listed: 1890 LATEST PUBLICATIONS - JULY 2009:
The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the worlds leading biopharma companies.
Essential reading if you want to protect your business in the US, assess the potential for becoming a player in what could be a new channel or a supplier to it, or are concerned about the knock-on effects in the countries named as potential sources.
Dr Andree Bates explains how eMarketing can be a challenge. However, with some company initiative, firm goals and insider knowledge provided by this report, marketers can also find eMarketing to be an empowering opportunity for their brands. In this timely and comprehensive Expert Review, Emma D'Arcy of myPHID argues that the future of interactions between industry and the medical community will be about openly aligning aspirations and ambitions. This expert article was written by Steven Simoens and first published in Journal of Generic Medicines, Volume 6, Number 2, April 2009
FEATURED PUBLISHER: PharmaVision was created by Dr Cheryl Lee Barton in 2002 to provide independent, tailor made pharmaceutical thematic research to investment houses, competitive intelligence specialists and pharmaceutical companies. The research reports combine independent scientific analysis with market models to forecast the potential growth of key developmental products and technologies. Pharmavision was formed in order to write and publish independent and impartial analysis of the pharmaceutical industry with a focus on drug delivery, it’s players, their products and the issues surrounding this specialist sector. Recent titles include:
Dr Paul Evers explains how the biopharm field represents a major opportunity for generic manufacturers with sufficient resources to withstand the relatively high development costs and the technological demand.
Stem cell-derived therapeutics are on the brink of a new era, with a handful of therapies expected on the market within the next 2 or 3 years and a growing pool of companies is investing heavily to bring this rapidly moving science to the clinic.
The report summarizes some of the latest developments in CV drug development and devices and analyzes some of the most promising solutions which drug delivery companies and device manufacturers are providing in order to address unmet clinical needs.
This expert report, by Ruth Ohlsen and Cheryl Barton, summarizes the latest developments in CNE therapies and analyzes some of the most promising solutions which companies are providing in order to address clinical needs.
Vaccines are a vibrant area of pharmaceutical development. The activity in the marketplace has grown steadily over the past few years and looks set to continue and increase in the near future. This report is by Sara Sleigh and Cheryl Barton.
This expert report, by Paul Evers and Cheryl Barton, summarizes the latest developments in treatment for diabetes and analyzes some of the most promising solutions which companies are providing in order to address clinical needs.
This expert report, by Cheryl Barton, summarizes the latest developments in cancer drug development and analyzes some of the most promising solutions which drug delivery companies are providing in order to address this unmet clinical need.
PUBLICATIONS ARE AVAILABLE FROM THE FOLLOWING PUBLISHERS: :: View our full list of titles from Bridgehead International :: View our full list of titles from Chiltern International :: View our full list of titles from Core Medical Publishing :: View our full list of titles from CurrentPartnering :: View our full list of titles from Dove Medical Press :: View our full list of titles from Eularis :: View our full list of titles from Euromed Communications :: View our full list of titles from eyeforpharma :: View our full list of titles from Garev Publishing International :: View our full list of titles from JUST Medical Media :: View our full list of titles from JustPharmaReports :: View our full list of titles from KeywordPharma :: View our full list of titles from Merit International Publishing :: View our full list of titles from the Medical Science Liaison Institute :: View our full list of titles from Palgrave Macmillan :: View our full list of titles from Pelican Publications UK :: View our full list of titles from Performance Management Coaching :: View our full list of titles from Pharmalicensing :: View our full list of titles from PharmaVentures :: View our full list of titles from PharmaVision :: View our full list of titles from Remedica Publishing :: View our full list of titles from Rx Communications |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
|
Affiliates | About Us | Contact Us | Terms ThePharmYard is an initiative for the international medical and pharmaceutical industries from NetworkPharma Ltd. Copyright 2009 Other services managed by NetworkPharma: [www.EuropeanCMEforum.eu] [www.KeywordPharma.com] [www.MedCommsNetworking.co.uk] [www.ThePublicationPlan.com] We accept the following credit and debit cards:        
|
